News & Perspective

Oct 26, 2012

Oct 26, 2012

Investigation flags several issues at tainted steroid producer

(CIDRAP News) – The compounding pharmacy that produced tainted steroid injections implicated in a multistate fungal meningitis outbreak had problems maintaining the clean room where the drugs were processed, according to a federal report today that found, for example, greenish residue on the ceiling.

Oct 24, 2012

Oct 24, 2012

Report airs problems at firm linked to fungal meningitis outbreak

(CIDRAP News) – Massachusetts officials yesterday said New England Compounding Center (NECC), the firm linked to a multistate fungal meningitis outbreak, sent shipments from two of the recalled lots before it received sterility testing results.

Oct 23, 2012

Oct 23, 2012

Fungal meningitis outbreak cases top 300

(CIDRAP News) – Eleven more cases were reported in a multistate fungal meningitis outbreak linked to contaminated steroid injections, including the first patient from Georgia, the US Centers for Disease Control and Prevention (CDC) reported today.

Oct 19, 2012

Oct 19, 2012

Report describes case that launched meningitis outbreak probe

(CIDRAP News) – A medical team from Tennessee today described the diagnosis and medical care of the first patient sickened in the ongoing fungal meningitis outbreak, the case that triggered an investigation by the state's public health officials and led to the uncovering of the problem.

Oct 17, 2012

Oct 17, 2012

Fungal meningitis toll rises as feds raid pharmacy

(CIDRAP News) – Fourteen more cases and four more deaths were reported today in a multistate fungal meningitis outbreak linked to contaminated steroids provided by a Massachusetts pharmacy, which was raided yesterday by federal agents.

Oct 16, 2012

Oct 16, 2012

Warnings, cases expand in fungal meningitis outbreak

(CIDRAP News) – Nineteen more patients have been sickened in a fungal meningitis outbreak linked to contaminated steroid injections, and a federal official today urged clinicians to contact patients who received other drugs made by the company involved, in view of worrisome investigative findings.

Pages

Sort Results

 

Narrow results

by Topic

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»